INTERNAL CONTROL RPT

Report of Independent Registered Public Accounting Firm
To the Board of Trustees of The Dimensional ETF Trust and
Shareholders of the Funds listed in Appendix A, (hereafter
collectively referred to as the "Funds")
In planning and performing our audits of the financial
statements of the Funds as of and for the year ended October 31,
2022, in accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), we
considered the Funds' internal control over financial reporting,
including controls over safeguarding securities, as a basis for
designing our auditing procedures for the purpose of expressing
our opinion on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of expressing
an opinion on the effectiveness of the Funds' internal control
over financial reporting.  Accordingly, we do not express an
opinion on the effectiveness of the Funds' internal control
over financial reporting.
The management of the Funds is responsible for establishing and
 maintaining effective internal control over financial reporting
..  In fulfilling this responsibility, estimates and judgments by
 management are required to assess the expected benefits and
related costs of controls. A company's internal control over
financial reporting is a process designed to provide reasonable
 assurance regarding the reliability of financial reporting and
 the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles.
A company's internal control over financial reporting includes
 those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately
and fairly reflect the transactions and dispositions of the
assets of the company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit preparation
of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the
 company are being made only in accordance with authorizations of
 management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of a company's
assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting
exists when the design or operation of a control does not allow
management or employees, in the normal course of performing
their assigned functions, to prevent or detect misstatements
on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a
material misstatement of the company's annual or interim
financial statements will not be prevented or detected on a
timely basis.
Our consideration of the Funds' internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
internal control over financial reporting that might be material
weaknesses under standards established by the PCAOB.  However, we
noted no deficiencies in the Funds' internal control over
financial reporting and its operation, including controls over
safeguarding securities, that we consider to be a material
weakness as defined above as of October 31, 2022.
PricewaterhouseCoopers LLP, Two Commerce Square, Suite 1800, 2001
Market Street, Philadelphia, PA 19103-7042
	T: (267) 330-3000, F: (267) 330-3300, www.pwc.com/us  	1
This report is intended solely for the information and use of the
Board of Trustees of The Dimensional ETF Trust and the Securities
and Exchange Commission and is not intended to be and should not
be used by anyone other than these specified parties.

Philadelphia, Pennsylvania
December 22, 2022
PricewaterhouseCoopers LLP, Two Commerce Square, Suite 1800,
2001 Market Street, Philadelphia, PA 19103-7042 T: (267)
330-3000, F: (267) 330-3300, www.pwc.com/us
Appendix A
Dimensional US Equity ETF
Dimensional U.S. Small Cap ETF
Dimensional US Targeted Value ETF
Dimensional U.S. Core Equity 2 ETF
Dimensional US Marketwide Value ETF
Dimensional International Value ETF
Dimensional World ex U.S. Core Equity 2 ETF
Dimensional US Core Equity Market ETF
Dimensional International Core Equity Market ETF
Dimensional Emerging Core Equity Market ETF
Dimensional US High Profitability ETF*
Dimensional US Real Estate ETF*
Dimensional US Small Cap Value ETF*
Dimensional International Core Equity 2 ETF**
Dimensional International Small Cap Value ETF**
Dimensional International Small Cap ETF**
Dimensional International High Profitability ETF**
Dimensional Emerging Markets High Profitability ETF***
Dimensional Emerging Markets Value ETF***
Dimensional Emerging Markets Core Equity 2 ETF***
Dimensional Core Fixed Income ETF****
Dimensional Short-Duration Fixed Income ETF****
Dimensional Inflation-Protected Securities ETF****
Dimensional National Municipal Bond ETF****
*For the period February 23, 2022 (commencement of operations)
through October 31, 2022
**For the period March 23, 2022 (commencement of operations)
through October 31, 2022
***For the period April 26, 2022 (commencement of operations)
through October 31, 2022
****For the period November 15, 2021 (commencement of operations)
through October 31, 2022
PricewaterhouseCoopers LLP, Two Commerce Square, Suite 1800, 2001
Market Street, Philadelphia, PA
19103-7042 T: (267) 330-3000, F: (267) 330-3300, www.pwc.com/us

OTHER REQUIRED INFO

Certificate of Chief Compliance Officer
In regard to the Interfund Lending program, I certify that each
Portfolio and the Adviser have established procedures reasonably
designed to achieve compliance with the terms and conditions of
the exemptive order dated April 2, 2014, pursuant to certain
sections of the Investment Company Act of 1940. These procedures,
which have been previously approved by the Board of Directors/
Trustees of the Portfolios, include the following objectives:
(a) that the Interfund Loan Rate will be higher than the Repo
Rate, and, if applicable, the one-day yield on any money market
fund in which the lending Portfolio could otherwise invest, but
lower than the Bank Loan Rate;
(b) compliance with the collateral requirements as set forth in
the application for exemptive relief filed on September 5, 2013,
and amended on February 18, 2014;
(c) compliance with the percentage limitations on interfund
borrowing and lending;
(d) allocation of interfund borrowing and lending demand in an
equitable manner and in accordance with procedures established
by the Board; and
(e) that the Interfund Loan Rate does not exceed the interest rate
on any third-party borrowings of a borrowing Portfolio at the time
of the Interfund Loan.

________________________
Randy Olson
Chief Compliance Officer
January 3, 2023

OTHER REQUIRED INFO

This amended Form N-CEN filing replaces the registrant's
Form N-CEN, as previously filed under accession number
0001752724-23-002765. The statutory exemptions relied
on for certain funds have been amended.